Medicinal Products

Arquist 250 mikrograma po potisku, stlačeni inhalat, suspenzija

Name Arquist 250 mikrograma po potisku, stlačeni inhalat, suspenzija
Former Name Truflo 250 mikrograma/dozi, stlačeni inhalat, suspenzija
Marketing Authorisation Number HR-H-620322804
Active Substance flutikazonpropionat
Composition jedna odmjerena doza sadrži 250 mikrograma flutikazonpropionata
Pharmaceutical Form stlačeni inhalat, suspenzija
Manufacturer S&D Pharma CZ, spol. s r.o, Pchery (Pharmos a.s. facility), Češka
Glenmark Pharmaceuticals s.r.o., Vysoké Mýto, Češka
Cipla Europe NV, Antwerpen, Belgija
Marketing Authorisation Holder Cipla Europe NV, De Keyserlei 60C, Bus 1301, Antwerpen, Belgija
Marketing Authorisation Date 13.08.2020
MA Period of Validity unlimited
MA Revocation Date 12.12.2025*
Classification Number UP/I-530-09/19-02/149
Registration Number 381-12-01/70-20-02
Prescription Medicinal product subject to medical prescription
Type of prescription ponovljivi recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code R03BA05
Marketing status trajni prekid opskrbe
SmPC download
PL download
Public Assessment Report download

*Note

Marketing authorisation has been revoked by request of the marketing authorisation holder. In accordance with Article 113 of Medicinal Products Act (Official Gazette No. 76/13), only a medicinal product in respect of which a marketing authorisation has been granted by the Agency for Medicinal Products and Medical Devices or the European Commision, and a medicinal product in respect of which an authorisation for parallel import or parallel distribution has been granted may be placed on the market of the Republic of Croatia. By way of derogation from this provision, a batch of medicinal product may be on the market for no longer than 18 months following the expiry of revocation of the marketing authorisation, unless its shelf life expires first.

Packaging

Back